ITW Board of Directors Declares Quarterly Dividend GLENVIEW, Ill., Feb. 13, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Illinois Tool Works Inc. (NYSE: ITW) declared a dividend on the company's common stock of $1.61 per share for the first quarter of 2026. The dividend equates to $6.44 per share on a full-year basis. The dividend will be paid on April 9, 2026 to shareholders of record as of March 31, 2026. About Illinois Tool WorksITW (NYSE: ITW) is a Fortune 300 global multi-industrial manufacturing leader with revenue of $16 billion in 2025. The company’s seven industry-leading ...
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on Thursday, February 26, 2026. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-r...
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism This is the third program that successfully combines Entera’s oral peptide N-Tab® platform with OPKO’s advanced protein chemistry capabilities The companies have accelerated this program and aim to file an investigational new drug (IND) application in late 2026 Injectable and oral oxyntomodulin (dual GLP-1/glucagon analog) for metabolic and fibrotic disorders advancing with initial Phase 1 data from injectable oxyntomodulin (OXM) expected in late 2026; o...
ITW Reports Fourth Quarter and Full Year 2025 Results Fourth Quarter 2025 Highlights Revenue of $4.1 billion, an increase of 4.1%Operating margin of 26.5%, as enterprise initiatives contributed 140 bpsGAAP EPS of $2.72, an increase of 7% 2025 Highlights Revenue of $16 billion, an increase of 0.9%Customer-Back Innovation contributed 2.4% to revenue growth, an increase of 40 bpsOperating margin of 26.3%, as enterprise initiatives contributed 130 bpsGAAP EPS of $10.49 exceeded the prior guidance mid-point of $10.45 2026 Guidance Revenue growth of 2 to 4%, organic growth of 1 to 3%Operatin...
ITW Schedules Fourth Quarter and Full Year 2025 Earnings Webcast GLENVIEW, Ill., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Illinois Tool Works Inc. (NYSE: ITW) will issue its fourth quarter and full year 2025 results on Tuesday, February 3, 2026, at 7:00 a.m. CST. Following the release, ITW will hold its fourth quarter and full year 2025 earnings webcast at 9:00 a.m. CST. To access the webcast for the event, please click on the following link: If you are a participant on the conference call, please dial 1-888-660-6652 (domestic) or 1-646-960-0554 (international) 10 minutes prior to the 9:00 a.m...
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference MIAMI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 44th Annual J.P. Morgan Healthcare Conference, being held January 12-15, 2026, at the Westin St. Francis Hotel in San Francisco. Management will be hosting one-on-one meetings with investors and will be participating in a fireside chat on Wednesday, January 14th at 1:30 p.m. Pacific time. The fireside chat will be webcast live and available for replay in the Investors sectio...
A director at Illinois Tool Works Inc gave away/bought 13,418 shares at 0.000USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.